The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Pravitin 40 mg Tablets

40 milligram(s) Tablet

Rowex LtdPA0711/058/004

Main Information

Trade NamePravitin 40 mg Tablets
Active SubstancesPravastatin sodium
Strength40 milligram(s)
Dosage FormTablet
Licence HolderRowex Ltd
Licence NumberPA0711/058/004

Group Information

ATC CodeC10AA HMG CoA reductase inhibitors
C10AA03 pravastatin


Licence Issued14/05/2004
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0014-004-014
Interchangeable List DocumentPDF of Interchangeable List
« Back